EPAM Systems Inc vs Humana Inc — how do they compare? EPAM Systems Inc trades at $113.24 (market cap $5.87B), while Humana Inc trades at $431.03 (market cap $46.49B). The key difference: Humana Inc is far larger — about 7.9× EPAM Systems Inc's market cap, and Humana Inc pays a 0.91% dividend while EPAM Systems Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold EPAM Systems Inc for 37 Days and Humana Inc for 51 Days on average.
| EPAM | HUM | |
|---|---|---|
Market Cap | $5.87B | $46.49B |
Volume | 847,420 | 2,567,704 |
Sector | Technology | Health |
52-Week High | $221.40 | $431.03 |
52-Week Low | $76.04 | $163.67 |
Typical Hold Time | 37 Days | 51 Days |
Enterprise Value | $5.24B | $53.84B |
Dividend Yield | — | 0.91% |
Signals from Pluang's Aura AI — not financial advice
EPAM trades at $113.86, up 5.11% on the day, with a bullish technical signal and strong quarterly earnings beats. Revenue grew to $5.46B in 2025, though net income margin compressed to 6.92%. The company maintains solid profitability with ROE of 11.18% and trades at a P/E of 15.45, below industry averages. Recent news highlights AI-native revenue growth and activist investor pressure for share buybacks.
The outlook is positive with a consensus price target of $119, representing 4.5% upside. Key catalysts include Q3 2026 earnings and AI service expansion, but risks involve North American growth slowdown and competitive pressures in digital transformation services.
Humana (HUM) trades at $387.12, down 2.37% today, with a bullish technical outlook supported by moving averages and strong institutional interest. The company shows steady revenue growth reaching $129.7B in 2025, though net margins have compressed to 0.88%. Recent analyst upgrades and a $460.74 consensus price target suggest upside potential, while Medicare Advantage plan changes and fiduciary scrutiny present near-term headwinds.
The stock offers value with a low P/S ratio of 0.32x and consistent earnings beats, but faces margin pressure and regulatory risks. Institutional accumulation and positive technicals support a constructive outlook, though investors should monitor enrollment trends and cost management execution for sustained growth.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
EPAM Systems Inc provides software product development and digital platform engineering services to clients located around the world. The company services include Software Product Development, Custom Application Development, Application Testing, Enterprise Application Platforms, Application Maintenance, and Support and Infrastructure Management. The company focuses on innovative and scalable software solutions. The company uses industry standard and custom developed technology, tools, and platforms to deliver results to handle business challenges. The company primarily offers its solutions in the following industries: financial services, travel and consumer, software and hi-tech, life sciences and healthcare. The majority of revenue is generated from North American clients.
Read more on EPAM →Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →